OpenAlex
PricingAboutJobs
Log inGet started
Work

The emerging role of MET/HGF inhibitors in oncology

HTML

Year: 2013
Type: review
Source: Cancer Treatment Reviews
DOI: 10.1016/j.ctrv.2013.02.001
Authors: Giorgio V. Scagliotti, Silvia Novello, Joachim von Pawel
Institutions: Ospedale San Luigi Gonzaga, University of Turin, Asklepios Fachkliniken München-Gauting
Language: English

Topic: Cancer Mechanisms and Therapy
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: MET receptor tyrosine kinase, hepatocyte growth factor, targeted cancer therapy, tivantinib, cabozantinib, onartuzumab, crizotinib, rilotumumab, non-small cell lung cancer, hepatocellular carcinoma, gastric cancer, metastasis, biomarkers, patient selection
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2055191970
FWCI: 2.932
Cites: 125
Cited by: 211
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security